Global Poloxamer 188 Excipients Market Growth 2024-2030
Poloxamer 188 is a pharmaceutical excipient. It is a nonionic linear copolymer having an average molecular weight of 8400 Daltons and is also referred to as PLURONIC F68, FLOCOR and RheothRx. The copolymer was approved by the FDA nearly 50 years ago as a therapeutic reagent to reduce viscosity in the blood before transfusions.
The global Poloxamer 188 Excipients market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
ReportPrime, Inc. (LPI) ' newest research report, the “Poloxamer 188 Excipients Industry Forecast” looks at past sales and reviews total world Poloxamer 188 Excipients sales in 2023, providing a comprehensive analysis by region and market sector of projected Poloxamer 188 Excipients sales for 2024 through 2030.
- Key Features:
- Product segmentation, company formation, revenue, and market share
- Latest development and M&A activity
- Strategies of leading global companies
- Segmentation by Type:
- Micronized Poloxamer 188
- Ordinary Poloxamer 188
- Segmentation by Application:
- Injectable Formulation
- Oral Formulation
- Topical Formulation
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Companies Coverage:
- BASF
- Croda
- Hubei Hengshuo Chemical
- Nanjing Well Pharmaceutical
- CD Formulation
Key Questions Addressed in this Report:
- What is the 10-year outlook for the global Poloxamer 188 Excipients market?
- What factors are driving Poloxamer 188 Excipients market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Poloxamer 188 Excipients market opportunities vary by end market size?
- How does Poloxamer 188 Excipients break out by Type, by Application?
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market